From: TIMP-1 and VEGF-165 serum concentration during first-line therapy of ovarian cancer patients
 | Response (% decrease of CA-125) | |
---|---|---|
 | p-value | correlation coefficient r |
TIMP-1 before surgery | 0.375 | 0.174 |
TIMP-1 before CTX | 0.150 | 0.265 |
TIMP-1 during CTX | 0.480 | 0.127 |
TIMP-1 after CTX | 0.554 | 0.107 |
VEGF before surgery | 0.725 | -0.07 |
VEGF before CTX | 0.729 | 0.065 |
VEGF during CTX | 0.414 | -0.147 |
VEGF after CTX | 0.671 | -0.077 |